• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    PetMeds® Hires Christine Chambers as Chief Financial Officer

    7/22/22 4:00:00 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $PETS alert in real time by email

    Seasoned executive brings a wealth of financial leadership to further accelerate the company's digital transformation.

    DELRAY BEACH, Fla., July 22, 2022 /PRNewswire-PRWeb/ -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health Expert®, announces the appointment of Christine Chambers as its Chief Financial Officer, effective on August 3.

    Chambers is an experienced finance professional with extensive knowledge in the digital consumer space, most recently serving as Senior Vice President, CFO and Treasurer of Seattle-based RealNetworks. Prior to that, she was Vice President, Finance at Rosetta Stone. Chambers also has served as Deputy Director, Budget and Planning at the Bill & Melinda Gates Foundation. She earned an MBA from the University of Washington and a bachelor's degree in finance from Loughborough University, UK. She is an Associate Member of the Chartered Global Management Accountants (CGMA).

    "We have made a lot of progress over the last several quarters to reinvigorate the iconic PetMeds business," said Matt Hulett, President and CEO of PedMed Express. "We have invested in people, product, and strategy, including our foray into the pet telemedicine space. Our new leadership team has both digital transformation and scale experience, and the Board and I are thrilled to welcome Christine to the company. She is a seasoned finance professional with extensive experience in digital transformation in public and private companies. We have worked closely together for over 20 years, and I know first-hand that she has the turnaround chops and experience to help PetMeds into its next phase of growth."

    Chambers, who will report to Hulett, succeeds Bruce Rosenbloom, who will work with the company through a transitionary period for several months to ensure a smooth handoff. "The Board and I would like to thank Bruce for his myriad contributions to PetMeds through over 20 years of service to the company," Hulett added.

    "I am beyond happy and grateful for the opportunity to be working with Matt Hulett and the PetMeds team during this exciting period of growth and transformation," Chambers said. "I look forward to adding to the company's operational excellence in the realms of finance, budget, planning, governance, and more. And, of course, I am eager to help PetMeds provide the best products and services to millions of pet parents."

    ABOUT PETMEDS

    Founded in 1996, PetMed Express is Your Trusted Pet Health Expert®, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at petmeds.com.

    FORWARD LOOKING STATEMENTS: The statements contained in this press release that are not purely historical are forward-looking statements, including statements regarding PetMeds' expectations, beliefs, intentions or strategies regarding the future. All forward-looking statements included in this press release are based upon information available to PetMeds as of the date hereof, and PetMeds assumes no obligation to update any such forward-looking statements. Forward-looking statements involve risks and uncertainties, which could cause actual results to differ materially from those projected. These and other risks relating to PetMed' business are set forth inPetMeds' Form 10-K for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission.

    MEDIA CONTACT

    Mary Eva Tredway

    Butin PR

    [email protected]

    Media Contact

    Leah Walker, PetMeds, 5615264444, [email protected]

    Twitter

     

    SOURCE PetMeds

    Get the next $PETS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PETS

    DatePrice TargetRatingAnalyst
    5/25/2023$20.00Buy
    Lake Street
    1/25/2022$25.00 → $21.00Underweight
    Morgan Stanley
    1/20/2022$32.00Neutral → Buy
    Sidoti
    11/18/2021$25.00Underweight
    Morgan Stanley
    10/1/2021$28.00Hold
    Jefferies
    8/5/2021$22.00Underperform
    Credit Suisse
    More analyst ratings

    $PETS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on PetMed Express with a new price target

      Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00

      5/25/23 9:17:49 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Morgan Stanley reiterated coverage on PetMed Express with a new price target

      Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously

      1/25/22 10:17:17 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express upgraded by Sidoti with a new price target

      Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00

      1/20/22 9:13:56 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Nina Capital Holdings Inc. bought $98,375 worth of shares (25,000 units at $3.94), increasing direct ownership by 0.99% to 2,550,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      6/4/25 4:15:58 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $96,500 worth of shares (25,000 units at $3.86), increasing direct ownership by 1% to 2,525,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/23/25 4:15:13 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Silvercape Investments Ltd bought $29,234 worth of shares (7,401 units at $3.95), increasing direct ownership by 0.32% to 2,307,719 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/22/25 10:55:21 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples